Apex Biotechnology Market Cap

Apex Biotechnology has a market cap or net worth of 3.12 billion as of May 20, 2025. Its market cap has decreased by -7.83% in one year.

Market Cap

3.12B

Enterprise Value

2.64B

Revenue

1.96B

Ranking

n/a

PE Ratio

19.51

Stock Price

31.40

Market Cap Chart

Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.12B, an increase of 118.84%. That is a compound annual growth rate of 3.36%.

Market Cap History

Date	Market Cap	% Change
May 19, 2025	3.12B	3.65%
Dec 31, 2024	3.01B	-25.31%
Dec 29, 2023	4.03B	57.73%
Dec 30, 2022	2.55B	-1.73%
Dec 30, 2021	2.60B	10.38%
Dec 31, 2020	2.35B	-16.91%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.35B
Caliway Biopharmaceuticals	128.17B
Bora Pharmaceuticals Co., LTD.	73.69B
Lotus Pharmaceutical	58.99B
Polaris Group	33.43B
Oneness Biotech	29.80B
Pegavision	27.38B
Center Laboratories	27.38B

Market Cap Rankings